AzTrials
AzTrials

HemiplegiaNCT02254876

Effectiveness of NeuroMuscular Taping on Painful Hemiplegic Shoulder

A study testing Standard physical therapy program and NeuroMuscular Taping (NMT) in people with Hemiplegia, run by University of Bologna at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Painful Shoulder Syndrome is a frequent complication after stroke occurring in between 5% and 84% of patients, often having a strong impact on their well-being and resulting in delays achieving rehabilitative objectives. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Hemiplegia
What is being tested?
Standard physical therapy program and NeuroMuscular Taping (NMT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteItaly
Study dates
Sep 2013to Jan 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Right or left hemiplegia resulting from an ischemic or hemorrhagic stroke
  • Painful Shoulder Syndrome, with pain at rest and during functional movement of the shoulder girdle
  • Spasticity with an Ashworth score greater than or equal to 1.

Who cannot join

  • Flaccidity
  • Thermoalgesic sensitivity deficits
  • Previous surgery to the shoulder
  • Cognitive impairment
  • Taking anti-inflammatory drugs and/or muscle relaxants during the course of the trial

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Policlinico S.Orsola-Malpighi

    Bologna, Emilia-Romagna, 40138

Other trials in Italy

About this study

Official title: Effectiveness of NeuroMuscular Taping in a Population of Post Stroke Hemiplegic Patients Suffering From Painful Shoulder Syndrome - Randomized Controlled Trial (RCT)

Painful Shoulder Syndrome is a frequent complication after stroke occurring in between 5% and 84% of patients, often having a strong impact on their well-being and resulting in delays achieving rehabilitative objectives.

The aim of the study is to demonstrate the effectiveness of Neuromuscular Taping in a population of post-stroke hemiplegic patients suffering from painful shoulder syndrome with respect to pain, spasticity and range of motion.

Read the detailed description

The study will use two groups according to the methodology of Randomized Controlled Trials. Both components of the two groups were treated by four rehabilitation sessions defined as "standard". This involves joint health and passive mobility for the glenohumeral and scapulothoracic joints for a period of about 45 minutes each.

The patients of the sample group underwent the application of the NeuroMuscular Taping (NMT) before each rehabilitative session. The control group was addressed exclusively to the "standard" treatment. The sessions were spaced apart about five days to ensure the optimum adhesion of NMT.

The results were evaluated by administering rating scales for pain (VAS) and spasticity (Modified Ashworth Scale). The ROM was evaluated using the manual goniometer. The outcomes (Pain, Spasticity, ROM) were assessed at base line, before and after each treatment session and at 1 month follow up.

Conditions
Hemiplegia
Being tested
Standard physical therapy program, NeuroMuscular Taping (NMT)
Keywords
Stroke, Hemiplegia, Painful shoulder Syndrome, NeuroMuscolar Taping
Medical subject headings
Hemiplegia, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard physical therapy programOther

    Standard physical therapy program in this study involves joint health and passive mobility at the level of the shoulder girdle and upper limb affected by Painful Shoulder Syndrome associated with the modulation of hypertonic muscle groups.

  • NeuroMuscular Taping (NMT)Other

    The NeuroMuscular Taping (NMT) consists of the application on the skin of an adhesive tape with a particular structure to elastic waves and with characteristics comparable to those cutaneous. Because of these characterises it allows activation of endogenous analgesic, structural and muscular support, vascular and lymphatic activation.

    In this study the NMT is applied with decompressive mode on Pectoralis Major, Deltoids, Supraspinatus.

Study groups in NCT02254876
Study groupRoleWhat they receive
Standard physical therapy programActive comparatorStandard physical therapy program is delivered for four rehabilitation sessions for a period of about 45 minutes each.
Receives: Other: Standard physical therapy program
NeuroMuscular Taping (NMT)ExperimentalNeuroMuscular Taping is delivered in addiction to the "Standard Treatment" for four rehabilitation sessions. The sessions were spaced apart about five days to ensure the optimum adhesion of the NMT.
Receives: Other: Standard physical therapy program; Other: NeuroMuscular Taping (NMT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain

    The investigators assessed this outcome with a Visual Analogue Scale (VAS).

    Measured: Before and after each treatment session and at 1 month follow up

Secondary outcomes (2)
  1. Spasticity

    The investigators assessed this outcome with the Modified Ashworth Scale.

    Measured: Before and after each treatment session and at 1 month follow up

  2. ROM

    The investigators assessed this outcome using manual goniometer.

    Measured: Before and after each treatment session and at one month follow up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2014 (estimated)
  2. Study startSep 2013
  3. Primary completionDec 2014
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02254876
Sponsor's protocol ID
4496/2013
Status last verified
May 2015
First submitted
29 Sep 2014
Last updated
29 May 2015
Results posted
No
Data monitoring committee
No

Publications

  • Camerota F, Galli M, Cimolin V, Celletti C, Ancillao A, Blow D, Albertini G. Neuromuscular taping for the upper limb in Cerebral Palsy: A case study in a patient with hemiplegia. Dev Neurorehabil. 2014 Dec;17(6):384-7. doi: 10.3109/17518423.2013.830152. Epub 2013 Oct 2.

    PubMed 24087981
  • Murie-Fernandez M, Carmona Iragui M, Gnanakumar V, Meyer M, Foley N, Teasell R. [Painful hemiplegic shoulder in stroke patients: causes and management]. Neurologia. 2012 May;27(4):234-44. doi: 10.1016/j.nrl.2011.02.010. Epub 2011 Apr 22. Spanish.

    PubMed 21514698
  • Smith M. Management of hemiplegic shoulder pain following stroke. Nurs Stand. 2012 Jul 4-10;26(44):35-44. doi: 10.7748/ns2012.07.26.44.35.c9191.

    PubMed 22876427

Questions about this trial

What is this clinical trial studying?

A study testing Standard physical therapy program and NeuroMuscular Taping (NMT) in people with Hemiplegia, run by University of Bologna at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain (time frame: Before and after each treatment session and at 1 month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02254876, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in